Sportel 2020.
Methods | Randomised controlled trial lasting 6 weeks |
Participants | 68 uncontrolled moderate to severe asthmatic children between 6 and 18 years old who receive controller inhalation medication through the Nexthaler(R), Ellipta(R), or Spiromax(R) |
Interventions | Immediate smart feedback about the performed inhalations via a mobile application |
Outcomes | Asthma control can be assessed by means of spirometry (both at home and in the hospital) and (c‐)ACT questionnaires |
Notes | — |